- Home
- ATON vs SABS Comparison
ATON vs SABS Comparison
Compare ATON & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATON
- SABS
- Stock Information
- Founded
- ATON 1973
- SABS 2014
- Country
- ATON British Virgin Islands
- SABS United States
- Employees
- ATON N/A
- SABS N/A
- Industry
- ATON Oil & Gas Production
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- ATON Energy
- SABS Health Care
- Exchange
- ATON Nasdaq
- SABS Nasdaq
- Market Cap
- ATON 13.4M
- SABS 15.8M
- IPO Year
- ATON N/A
- SABS N/A
- Fundamental
- Price
- ATON $6.15
- SABS $2.46
- Analyst Decision
- ATON
- SABS Strong Buy
- Analyst Count
- ATON 0
- SABS 4
- Target Price
- ATON N/A
- SABS $9.50
- AVG Volume (30 Days)
- ATON 98.3K
- SABS 244.9K
- Earning Date
- ATON 09-30-2025
- SABS 11-05-2025
- Dividend Yield
- ATON N/A
- SABS N/A
- EPS Growth
- ATON N/A
- SABS N/A
- EPS
- ATON N/A
- SABS N/A
- Revenue
- ATON N/A
- SABS $114,698.00
- Revenue This Year
- ATON N/A
- SABS N/A
- Revenue Next Year
- ATON N/A
- SABS N/A
- P/E Ratio
- ATON N/A
- SABS N/A
- Revenue Growth
- ATON N/A
- SABS N/A
- 52 Week Low
- ATON $2.95
- SABS $1.00
- 52 Week High
- ATON $15.82
- SABS $6.60
- Technical
- Relative Strength Index (RSI)
- ATON N/A
- SABS 57.16
- Support Level
- ATON N/A
- SABS $2.05
- Resistance Level
- ATON N/A
- SABS $2.92
- Average True Range (ATR)
- ATON 0.00
- SABS 0.19
- MACD
- ATON 0.00
- SABS 0.05
- Stochastic Oscillator
- ATON 0.00
- SABS 47.18
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.